<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CQNGFKXX</identifier><date>2022</date><creator>Bele, Tadeja</creator><creator>Drobne, Damjana</creator><creator>Kononenko, Veno</creator><creator>Križaj, Igor</creator><creator>Novak, Sara</creator><creator>Turk, Tom</creator><relation>documents/doc/C/URN_NBN_SI_doc-CQNGFKXX_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CQNGFKXX_001.txt</relation><format format_type="issue">1</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 5-17</format><identifier identifier_type="COBISSID">120642819</identifier><identifier identifier_type="ISSN">1854-3073</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CQNGFKXX</identifier><language>slv</language><publisher>Društvo biologov Slovenije</publisher><source>Acta biologica slovenica</source><rights>BY-NC-ND</rights><subject language_type_id="slv">agonist</subject><subject language_type_id="slv">antagonisti</subject><subject language_type_id="slv">apoptoze</subject><subject language_type_id="slv">nikotin</subject><subject language_type_id="slv">pljuča</subject><subject language_type_id="slv">rak (medicina)</subject><title>Nicotinic acetylcholine receptor as a pharmacological target in lung cancer</title><title>Nikotinski acetilholinski receptor kot farmakološka tarča pri pljučnem raku</title></Record>